Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-28

Clinical Trial Update: PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease [NA]

View source ↗

Summary

A recruiting clinical trial evaluating proactive infliximab monitoring and optimization in inflammatory bowel disease, including Crohn's disease and ulcerative …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infliximab (infliximab)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Inflammatory Bowel Disease (IBD), Crohn Disease (CD) | NA | Status: RECRUITING